|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| EcoR1 Capital LLC
✚
|
|
|---|---|
| CRD # | 167121 |
| SEC # | 801-100470 |
| CIK # | 0001587114 |
| AUM | $3.9 B (2025-07-25) |
| Employees | 22 (41% Investors, 0% Brokers) |
| Phone | 415-754-3517 |
| Address | 357 Tehama Street San Francisco, CA 94103 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Zymeworks Inc | 0.3 | ||
| Apellis Pharmaceuticals Inc | 0.2 | ||
| Jazz Pharmaceuticals Inc | 0.2 | ||
| Anaptysbio Inc | 0.2 | ||
| Crinetics Pharmaceuticals Inc | 0.1 | ||
| Iteos Therapeutics Inc | 0.1 | ||
| CRISPR Therapeutics AG | 0.1 | ||
| Uniqure NV | 0.1 | ||
| BCTG Acquisition Corp | 0.1 | ||
| Xencor Inc | 0.0 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| VC | EcoR1 Venture Opportunity Fund LP | [2019-08-29] | 5.5 | 89.1 |
| HF | EcoR1 Special Opportunity Fund II LP | [2016-03-29] | 0.0 | 0.6 |
| HF | EcoR1 Special Opportunity Fund I LP | [2015-03-30] | 0.0 | 8.8 |
| HF | EcoR1 Capital Fund LP | [2014-03-25] | 117.8 | 252.0 |
| HF | EcoR1 Capital Fund Qualified LP | [2014-03-25] | 1,811.4 | 3,573.1 |
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 5 | 3.9 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 5 | 3.9 |
| By Discretionary | ||
| Discretionary | 5 | 3.9 |
| Non-Discretionary | 0 | 0.0 |
| Total | 5 | 3.9 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.8 | |
| United States Persons | 3.1 | |
| Total | 5 | 3.9 |
| Form D Directors | # Filings | # Firms | 2011 - 2025 |
|---|---|---|---|
| Oleg Nodelman | 13 | ||
| Scott Perlen | 8 | ||
| Sarah Marriott | 7 | ||
| EcoR1 Capital LLC | 5 | ||
| Biotech Opportunity GP LLC | 2 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0001587114] | |
| 3 | [0001587114] | |
| 4 | [0001587114] | |
| SC 13D | [0001587114] | |
| SC 13G | [0001587114] |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Freeport Financial Partners LLC
✚
|
IL | 4.0 |
|
Gates Capital Management Inc
✚
|
NY | 3.9 |
|
Acasta Partners US LLC
✚
|
3.9 | |
|
SPF Investment Management LP
✚
|
NY | 3.9 |
|
Lucid Management and Capital Partners LP
✚
|
NY | 3.9 |
|
North of South Capital LLP
✚
|
3.9 | |
|
North Reef Capital Management LP
✚
|
CA | 3.9 |
|
Summit Partners Public Asset Management LLC
✚
|
MA | 3.9 |
|
Tages Capital LLP
✚
|
3.8 | |
|
Ghisallo Capital Management LLC
✚
|
MA | 3.8 |